Article ID Journal Published Year Pages File Type
949199 Journal of Psychosomatic Research 2015 6 Pages PDF
Abstract

•The majority of study participants were in remission (74%), yet expressed concerns•Despite being in remission both depression and anxiety symptoms were notably high•Poor QOL was the most prevalent concern (n=150/51%)•Women were significantly more concerned about their QOL and treatments than men•Of note, the longer patients had IBD the more concerned they were about symptoms

ObjectiveThis mixed-methods study aimed to explore concerns and worries related to living with inflammatory bowel disease (IBD).MethodsOverall, 294 patients with a clinically established diagnosis of IBD were enrolled in this cross-sectional study. Concerns and worries were measured with one open-ended question. Measures of anxiety and depressive symptoms and disease activity were also administered. A thematic analysis was conducted and thematic map created. Spearman’s rho was used to identify univariate correlations between predictors and the main themes. Binary logistic regression was used to test the predictors of the main themes.ResultsDespite the majority of study participants being in IBD remission (74%, n=217), all but 11 reported significant IBD-related concerns. Twenty two percent reported symptoms of depression and 41% of anxiety. Four themes were identified: Quality of life (51%); Unpredictability (35%); Symptoms (34%) and Treatments (19%). Males and older people were less concerned about Quality of life (OR=.597, 95% CI: .363–.980 and OR=.980, 95% CI: .965–.995, respectively). Those in remission were less concerned about Symptoms (OR=.510, 95% CI: .281- .926) while those with longer disease duration worried more about the Symptoms (OR=1.035, 95% CI: 1.010–1.061). Males were less concerned about Treatments (OR=.422, 95% CI: .229–.777).ConclusionIBD patients report significant disease-related concerns even when in remission. Further exploration of what predicts patient concerns may help in shaping health-care delivery so that it better addresses patient needs.

Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , ,